TEMPE, Ariz., March 16, 2023—GT Medical Technologies, Inc. has appointed Michael A. Garcia, MD, MS, as its Chief Medical Officer.
In his new role, Dr. Garcia will expand the GammaTile® Therapy clinical study pipeline, support research and development, lead medical affairs, and promote additional efforts for expanding the evidence-based use of GammaTile Therapy and its incorporation into oncology care guidelines.
Dr. Garcia holds a bachelor’s and master’s degree in Biological Sciences from Stanford University and earned his medical degree from Harvard Medical School. Prior to joining GT Medical Technologies, Dr. Garcia was an Associate Professor in Radiation Oncology at the Barrow Neurological Institute, a leading neurological disease treatment and research institution.
“Caring for patients with brain tumors has been one of the greatest privileges of my life. While walking with patients and their families during their treatment journey, I’ve seen that they desperately need better treatment options,” said Dr. Garcia.